Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study-Reference-Cited by-同舟云学术

Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: a prospective multi-center study

Published:2013-04-23 Issue:1 Volume:8 Page:
ISSN:1748-717X
Container-title:Radiation Oncology
language:en
Short-container-title:Radiat Oncol

Author:

Gez Eliahu,Cytron Shmuel,Yosef Rahamin Ben,London Daniel,Corn Benjamin W,Alani Shlomi,Scarzello Giovanni,Dal Moro Fabrizio,Sotti Guido,Zattoni Filiberto,Koziol Ike,Torre Taryn,Bassignani Matthew,Kalnicki Shalom,Ghavamian Reza,Blakaj Dukagjin,Anscher Mitchell,Sommerauer Martin,Jocham Dieter,Melchert Corinna,Huttenlocher Stefan,Kovacs Gyoergy,Garg Madhur

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1748-717X-8-96.pdf

Reference21 articles.

1. Martinez AA, Gonzalez J, Ye H, Ghilezan M, Shetty S, Kernen K, Gustafson G, Krauss D, Vicini F, Kestin L: Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer pts treated with hypofractionated high-dose-rate boost and external beam radiotherapy. Int J Radiat Oncol Biol Phys 2011, 79: 363-70. 10.1016/j.ijrobp.2009.10.035

2. Zelefsky MJ, Pei X, Chou JF, Schechter M, Kollmeier M, Cox B, Yamada Y, Fidaleo A, Sperling D, Happersett L, Zhang Z: Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes. Eur Urol 2011, 60: 1133-9. 10.1016/j.eururo.2011.08.029

3. Prada PJ, Mendez L, Fernández J, González H, Jiménez I, Arrojo E: Long-term biochemical results after high-doserate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer. Radiat Oncol 2012, 7: 31-38. 10.1186/1748-717X-7-31

4. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI: Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70: 1124-9. 10.1016/j.ijrobp.2007.11.044

5. Dolezel M, Odrazka K, Vaculikova M, Vanasek J, Sefrova J, Paluska P, Zouhar M, Jansa J, Macingova Z, Jarosova L, Brodak M, Moravek P, Hartmann: Dose Escalation in Prostate Radiotherapy up to 82Gy Using Simultaneous Integrated Boost Direct Comparison of Acute and Late Toxicity with 3D-CRT 74Gy and IMRT 78Gy. Strahlenther Onkol 2010, 186: 197-202. 10.1007/s00066-010-2065-x

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of rectal balloon spacer in patients with localized prostate cancer receiving external beam radiotherapy;Technical Innovations & Patient Support in Radiation Oncology;2024-03

2. Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer;Scientific Reports;2023-10-26

3. Poly-l-lactide-co-ε-caprolactone (PLCL) and poly-l-lactic acid (PLLA)/gelatin electrospun subacromial spacer improves extracellular matrix (ECM) deposition for the potential treatment of irreparable rotator cuff tears;International Journal of Biological Macromolecules;2023-08

4. Multicenter, dual fractionation scheme, single core lab comparison of rectal volume dose reduction following injection of two biodegradable perirectal spacers;Journal of Applied Clinical Medical Physics;2023-06-28

5. Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer;2023-04-24